Green Cross stocks attracting investors on influenza A

Published: 2009-09-01 06:59:00

Updated: 2009-09-01 06:59:00

As H1N1 influenza claimed the lives of three Koreans, shares of Green Cross Corp. have surged recently and the company’s total share values reached at 1.83 trillion won.

Indeed, Green Cross, the only Korean company with a facility for manufacturing vaccines for the flu, saw its share prices su...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK